BIOLASE, Inc. (BIOLQ)

Market Cap	7.32K -99.7%
Revenue (ttm)	46.03M -7.4%
Net Income	-15.97M
EPS	-0.71
Shares Out	36.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	15,617
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0000 - 0.0200
Beta	0.05
RSI	49.67
Earnings Date	n/a

About BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterlase (all-tissue) systems for cutting soft and hard tissue; and diode (s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 157
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIOLQ

Financial Performance

In 2023, BIOLASE's revenue was $49.16 million, an increase of 1.45% compared to the previous year's $48.46 million. Losses were -$37.62 million, 30.4% more than in 2022.